SS Innovations International (NASDAQ: SSII) is set to showcase its SSi Mantra surgical robotic system at the Society of Robotic Surgery (SRS) 2026 Annual Meeting, scheduled for July 23-26 in Hollywood, Florida. The event, one of the largest gatherings of robotic surgery specialists, will highlight the company’s expanding clinical experience and focus on remote surgical capabilities. The SSi Mantra will be demonstrated throughout the conference and featured in multiple technical sessions, including a live robotic telesurgery broadcast from India where a partial nephrectomy will be performed remotely.
Chairman and CEO Dr. Sudhir Srivastava will participate in several conference presentations covering telesurgery, robotic surgery adoption, and regulatory developments. The company’s presence at SRS 2026 underscores its commitment to advancing surgical robotics, particularly in enabling remote procedures that can expand access to specialized care. As of July 6, 2026, more than 12,375 procedures have been completed using the SSi Mantra system, including cardiac, pediatric, and telesurgical procedures. Approximately 2,100 physicians have been trained on the platform, which has been utilized across more than 170 different surgical procedures.
The SSi Mantra system represents a significant milestone in surgical robotics, offering a versatile platform capable of performing a wide range of minimally invasive procedures. The live telesurgery demonstration at SRS 2026 will showcase the system’s remote capabilities, potentially addressing healthcare disparities by enabling expert surgeons to operate on patients in distant locations. This technology could be particularly impactful in underserved regions where access to specialized surgical care is limited.
The company’s participation in SRS 2026 follows a series of regulatory and clinical milestones. The SSi Mantra has received approvals in multiple countries, including India, and is being evaluated for clearance in other markets. The growing number of procedures and trained physicians highlights the system’s acceptance among surgeons and its potential to compete with established robotic platforms. For more information about the SRS 2026 Annual Meeting, visit https://ibn.fm/FkgsY.
The implications of this announcement are far-reaching. As telesurgery becomes more feasible, it could transform the delivery of surgical care, reducing the need for patient travel and enabling real-time collaboration among specialists. SS Innovations’ progress with the SSi Mantra system positions it as a key player in this evolving field. The company’s newsroom provides updates and additional details at https://ibn.fm/SSII.
Forward-looking statements in this press release involve risks and uncertainties, including those described in the company’s filings with the SEC. Investors should consider these factors when evaluating the company’s future prospects.
